This document discusses central nervous system (CNS) depressants such as sedatives and hypnotics. It provides background on the history of CNS depressants including early uses of bromides and barbiturates. It describes the effects of CNS depressants such as reducing brain activity and awareness. Common types are discussed including benzodiazepines, barbiturates, and other depressants. Medical uses include treating anxiety and insomnia. Mechanisms of action involve enhancing the inhibitory neurotransmitter GABA. Patterns of abuse and dangers of overdose are also summarized.
Depressants are drugs that slow down the central nervous system and body functions. They were first discovered in 1864 and used as sedatives, tranquilizers, and for anesthesia before surgeries. Depressants affect the nervous system by slowing brain and spinal cord functions, the cardiovascular system by lowering heart rate and blood pressure, the respiratory system by potentially making users more prone to illness, and the digestive system if the liver is impacted. Their effects include slowed speech, fatigue, confusion, and in high doses, coma or death.
This chapter discusses depressants such as alcohol, benzodiazepines, and barbiturates. It outlines the history of depressant use from chloral hydrate to modern drugs. Barbiturates were introduced in the early 1900s and became widely abused. Benzodiazepines were introduced in the 1960s and have a larger safety margin than barbiturates. Inhalants like solvents, gases, and nitrites can also cause intoxicating effects similar to depressants when inhaled and have serious health risks. Both depressants and inhalants carry risks of dependence, overdose, and withdrawal symptoms when abused.
Depressants slow down (or “depress”)
the normal activity that goes on in the brain. Alcohol is a depressant.
Doctors often prescribe central nervous
system (CNS) depressants to patients who are anxious or can’t sleep. When
used as directed, CNS depressants are safe and helpful for people who need
them.
The document provides an overview of the four main classes of hallucinogenic drugs: serotonergic hallucinogens like LSD and psilocybin; methylated amphetamines like MDMA; anticholinergic hallucinogens found in plants; and dissociative anesthetics like PCP. It discusses the history of hallucinogen use from the 1960s counterculture movement to current trends, physiological and psychological effects of different classes of drugs, risks and adverse effects, and mechanisms of action in the brain.
Stimulants are drugs that increase alertness, energy, and bodily functions by stimulating the brain and nervous system. They have been used medically to treat conditions like narcolepsy and ADHD. However, stimulants can also be abused recreationally and lead to addiction. Common stimulants include caffeine, cocaine, amphetamines, and ingredients in energy drinks. While stimulants provide short-term effects like increased energy, they can cause serious long-term health problems if abused, such as heart disease, organ damage, and psychological issues.
Hallucinogens are a class of drugs that cause hallucinations or perceptual anomalies by disrupting serotonin production in the brain. There are several types of hallucinations involving sight, sound, smell, and touch. Hallucinogens can come from natural sources like mushrooms or synthetic sources and are consumed in various forms. While some hallucinogens have medical uses, adverse effects include anxiety, paranoia, and flashbacks. Treatment involves both medical and psychological approaches like reducing medication that triggers symptoms, using antipsychotics, and psychotherapy.
This document discusses CNS stimulants and drugs of abuse. It classifies CNS stimulants based on their site of action in the brain and effects. It describes convulsants and respiratory stimulants, psychomotor stimulants, and psychotomimetic drugs. It covers specific stimulants like amphetamines, cocaine, caffeine, and hallucinogens. It also discusses mechanisms of action, clinical uses, toxicity, and classifications of drugs of abuse. Addiction is described as compulsive drug use despite negative consequences due to adaptive changes in the brain's reward system.
Drugs are a major constraints in our community targeting adults and young people. Substance abuse education is vital to teach the society of the danger of all the types of drugs that are out there.
this slide serves the purpose of teaching people and making them aware. It defines what is substance abuse, the types of drugs and their examples, how it affects the neurotransmitters, the effects that drugs have on our body and mind.
Depressants are drugs that slow down the central nervous system and body functions. They were first discovered in 1864 and used as sedatives, tranquilizers, and for anesthesia before surgeries. Depressants affect the nervous system by slowing brain and spinal cord functions, the cardiovascular system by lowering heart rate and blood pressure, the respiratory system by potentially making users more prone to illness, and the digestive system if the liver is impacted. Their effects include slowed speech, fatigue, confusion, and in high doses, coma or death.
This chapter discusses depressants such as alcohol, benzodiazepines, and barbiturates. It outlines the history of depressant use from chloral hydrate to modern drugs. Barbiturates were introduced in the early 1900s and became widely abused. Benzodiazepines were introduced in the 1960s and have a larger safety margin than barbiturates. Inhalants like solvents, gases, and nitrites can also cause intoxicating effects similar to depressants when inhaled and have serious health risks. Both depressants and inhalants carry risks of dependence, overdose, and withdrawal symptoms when abused.
Depressants slow down (or “depress”)
the normal activity that goes on in the brain. Alcohol is a depressant.
Doctors often prescribe central nervous
system (CNS) depressants to patients who are anxious or can’t sleep. When
used as directed, CNS depressants are safe and helpful for people who need
them.
The document provides an overview of the four main classes of hallucinogenic drugs: serotonergic hallucinogens like LSD and psilocybin; methylated amphetamines like MDMA; anticholinergic hallucinogens found in plants; and dissociative anesthetics like PCP. It discusses the history of hallucinogen use from the 1960s counterculture movement to current trends, physiological and psychological effects of different classes of drugs, risks and adverse effects, and mechanisms of action in the brain.
Stimulants are drugs that increase alertness, energy, and bodily functions by stimulating the brain and nervous system. They have been used medically to treat conditions like narcolepsy and ADHD. However, stimulants can also be abused recreationally and lead to addiction. Common stimulants include caffeine, cocaine, amphetamines, and ingredients in energy drinks. While stimulants provide short-term effects like increased energy, they can cause serious long-term health problems if abused, such as heart disease, organ damage, and psychological issues.
Hallucinogens are a class of drugs that cause hallucinations or perceptual anomalies by disrupting serotonin production in the brain. There are several types of hallucinations involving sight, sound, smell, and touch. Hallucinogens can come from natural sources like mushrooms or synthetic sources and are consumed in various forms. While some hallucinogens have medical uses, adverse effects include anxiety, paranoia, and flashbacks. Treatment involves both medical and psychological approaches like reducing medication that triggers symptoms, using antipsychotics, and psychotherapy.
This document discusses CNS stimulants and drugs of abuse. It classifies CNS stimulants based on their site of action in the brain and effects. It describes convulsants and respiratory stimulants, psychomotor stimulants, and psychotomimetic drugs. It covers specific stimulants like amphetamines, cocaine, caffeine, and hallucinogens. It also discusses mechanisms of action, clinical uses, toxicity, and classifications of drugs of abuse. Addiction is described as compulsive drug use despite negative consequences due to adaptive changes in the brain's reward system.
Drugs are a major constraints in our community targeting adults and young people. Substance abuse education is vital to teach the society of the danger of all the types of drugs that are out there.
this slide serves the purpose of teaching people and making them aware. It defines what is substance abuse, the types of drugs and their examples, how it affects the neurotransmitters, the effects that drugs have on our body and mind.
Drug dependence
It is a physical or psychological condition resulting from repeated administration of mood-altering drugs.
It is a state characterized by a compulsion to take the drug on a continuous or periodic basis in order to experience its euphoriogenic effects.
If a mood-altering drug is unavailable, then the individual develops certain withdrawal symptoms.
Physical dependence + Psychological dependence
Drug addiction
Drug habituation
Drug abuse
Habit-forming drug
Central nervous system stimulants work by increasing levels of neurotransmitters like dopamine and norepinephrine. They cause initial feelings of euphoria and increased alertness and energy. However, regular use can lead to tolerance and dependence. Common stimulants include caffeine, nicotine, cocaine, and amphetamines. They are used both medically to treat conditions like ADHD, obesity, and narcolepsy, as well as recreationally for their mood enhancing effects. However, stimulants also carry health risks like increased blood pressure, anxiety, and addiction. Their effects are mediated through interactions with neurotransmitter systems in the brain.
This document defines key terms related to drugs of abuse and summarizes information about several commonly abused drugs. It defines pharmacology as the study of drug effects on biology, and defines stimulants, depressants, and hallucinogens based on their effects on the nervous system. It describes how heroin, alcohol, cocaine, and methamphetamine work in the body, including their drug targets in the brain and physiological and toxic effects.
This document summarizes the history and effects of amphetamines. It was first synthesized in 1887 but not used medically until 1934 as a decongestant. During World War II, amphetamines were used for their stimulant and performance-enhancing effects. Amphetamines work by increasing the neurotransmitters dopamine, serotonin, and norepinephrine. They can produce both helpful effects like happiness and energy, as well as harmful effects like addiction, aggression, and overdose risks. While they have therapeutic uses, amphetamines also carry misuse risks if used illegally or without medical supervision.
Hallucinogens, also known as psychedelic drugs, alter perception and can cause hallucinations. Some examples include LSD, DMT, PCP, and marijuana. Albert Hofmann first synthesized LSD in 1938, and hallucinogenic mushrooms have been used for thousands of years for religious or medicinal purposes by ancient cultures. While some advocate for medical uses, hallucinogens are currently illegal and can have harmful physical, emotional, and social effects if abused.
CNS stimulants are psychoactive drugs that can temporarily improve mental or physical function. They have medical uses like treating ADHD, narcolepsy, obesity, and depression. There are two types - psychomotor stimulants and hallucinogens. Psychomotor stimulants cause excitement and decrease fatigue while hallucinogens produce profound changes in thought patterns. Common psychomotor stimulants include caffeine, nicotine, amphetamines, cocaine, and methylphenidate which are used to treat various conditions. Hallucinogens include LSD and THC. CNS stimulant addiction can cause health issues and problems in relationships, work, and daily life.
The document provides information about various hallucinogenic drugs like PCP, LSD, and ecstasy. It discusses the pharmacological effects of these drugs on the brain and body. It also covers the potential symptoms of toxicity and overdose from hallucinogen use as well as myths and rumors surrounding these drugs. The goal is to educate students about hallucinogens and their consequences in order to help students make informed choices.
This document discusses hallucinogenic drugs. It defines different terms used to describe hallucinogens and describes the two main classes of hallucinogens - classical phantastica and deliriants. It focuses on LSD, describing its discovery, early uses, advocates like Timothy Leary, effects, and debates around its medical and therapeutic use. The document also briefly profiles several other common hallucinogenic plants and substances.
This document discusses drug abuse and its effects. It defines drugs as substances that alter mental or physical states, and distinguishes between medical and recreational uses. Commonly abused drugs are listed, including marijuana, methamphetamine, and cocaine. The document notes that drug addiction involves psychological and physical dependence, and impacts individuals through aggressive behavior and health issues, families through relationship and financial problems, and society through lost productivity and crime. Treatment involves pharmacological, social, and legal approaches, as well as family support.
This document summarizes different types of central nervous system (CNS) stimulants. It describes convulsants like strychnine that act by inhibiting the inhibitory neurotransmitter glycine. It also discusses analeptics like doxapram that stimulate respiration. Psychomotor stimulants such as amphetamines are described as producing excitement, euphoria and increased motor activity by blocking neurotransmitter reuptake or promoting release. Hallucinogens can induce changes in thought patterns and mood. The document provides examples and mechanisms of action for various classes of CNS stimulant drugs.
This document discusses poisoning from central nervous system stimulants like amphetamines and cocaine. It provides details on amphetamine poisoning including its mode of action, signs and symptoms, fatal dose, treatment, and post-mortem findings. For cocaine poisoning, it similarly outlines its introduction, routes of administration, mode of action, acute signs and symptoms, fatal dose, diagnosis, treatment, and post-mortem appearances. It also discusses chronic cocaine poisoning and its associated signs and symptoms.
This document discusses various commonly abused substances including amphetamines, cocaine, MDMA, synthetic cathinones, LSD, marijuana, synthetic cannabinoids, ethanol, and prescription drugs. It describes their mechanisms of action, effects, routes of administration, toxicity, and medical management for overdoses. Drug abuse is a serious public health issue and substances have become more potent and addictive over time.
Reviews the uses for benzodiazepines and barbiturates, the signs of intoxication and withdrawal, impact on sports performance. Continuing Education for mental health and substance abuse counselors and therapists.
Central nervous system (CNS) depressants are a class of drugs that slow down brain activity and cause muscles to relax. They include benzodiazepines, barbiturates, alcohol, opioids, and some sleeping pills. They work by enhancing the effects of the inhibitory neurotransmitter GABA at GABAA receptors in the brain, resulting in sedative, hypnotic, anxiolytic, and muscle relaxant effects. While effective for treating conditions like anxiety and insomnia, long-term use can lead to tolerance, addiction, and withdrawal symptoms.
This document provides information on various drugs and their effects. It discusses stimulants like caffeine, nicotine, and cocaine which speed up the nervous system, as well as depressants like alcohol and heroin which slow it down. Hallucinogens like LSD and ecstasy are described as altering a user's state of consciousness. Specific drugs like alcohol, marijuana, ecstasy, rohypnol, heroin, cocaine, and crystal meth are then outlined, with details of their methods of use, short and long term impacts on physical and mental health, and risks of addiction. The document concludes by discussing the societal effects of substance abuse like increased disease transmission and crime.
This document discusses the neurobiology of addiction. It provides an overview of neurotransmission, including action potentials, the neurotransmitter lifecycle, and receptor types. Specific neurotransmitters are examined, such as dopamine, GABA, glutamate, and opioids. The roles of these neurotransmitters in addiction and how various drugs affect neurotransmitter systems are described. Genetic and environmental factors that can contribute to addiction are also reviewed.
Stimulants work by blocking monoamine transporters like dopamine, increasing their levels in the brain. This can cause both acute effects like euphoria but also chronic addiction through changes in brain regions involved in reward. Management of acute intoxication focuses on stabilization while withdrawal typically resolves in 2 weeks with supportive care. Relapse prevention requires comprehensive psychosocial treatment though some medications may help reduce cocaine use.
Pharmacology document discusses central nervous system (CNS) depressants like alcohols, barbiturates, benzodiazepines, and newer non-benzodiazepine hypnotics. It describes their mechanisms of action, pharmacological effects on various body systems, classifications, and examples. Key points include ethanol and methanol acting as CNS depressants; barbiturates formerly used as hypnotics and sedatives but now replaced due to side effects; benzodiazepines having lower CNS depression than barbiturates; and newer non-benzodiazepine hypnotics like zolpidem and zaleplon acting on GABA receptors with improved
The document discusses inhalants, which are substances like solvents, aerosols, gases, and nitrites that are inhaled to get high. Over 2.6 million youth between 12-17 abuse inhalants each year, making them the fourth most abused substance. Inhalant use often begins before age 12 and can cause immediate effects like dizziness or death from sudden sniffing death syndrome. Long term effects include brain, liver, and kidney damage. Education is key to preventing inhalant abuse.
Inhalants are toxic vapors from substances like cleaning products and paint thinner that slow the body's functions. Short term effects include slurred speech, dizziness, and hallucinations. Long term use can cause muscle weakness, brain damage, and heart or lung damage. Repeated inhalation can cause sudden death from heart failure within minutes, called sudden sniffing death. Younger children abuse inhalants more than older children, and signs of abuse include red nose and loss of appetite.
Drug dependence
It is a physical or psychological condition resulting from repeated administration of mood-altering drugs.
It is a state characterized by a compulsion to take the drug on a continuous or periodic basis in order to experience its euphoriogenic effects.
If a mood-altering drug is unavailable, then the individual develops certain withdrawal symptoms.
Physical dependence + Psychological dependence
Drug addiction
Drug habituation
Drug abuse
Habit-forming drug
Central nervous system stimulants work by increasing levels of neurotransmitters like dopamine and norepinephrine. They cause initial feelings of euphoria and increased alertness and energy. However, regular use can lead to tolerance and dependence. Common stimulants include caffeine, nicotine, cocaine, and amphetamines. They are used both medically to treat conditions like ADHD, obesity, and narcolepsy, as well as recreationally for their mood enhancing effects. However, stimulants also carry health risks like increased blood pressure, anxiety, and addiction. Their effects are mediated through interactions with neurotransmitter systems in the brain.
This document defines key terms related to drugs of abuse and summarizes information about several commonly abused drugs. It defines pharmacology as the study of drug effects on biology, and defines stimulants, depressants, and hallucinogens based on their effects on the nervous system. It describes how heroin, alcohol, cocaine, and methamphetamine work in the body, including their drug targets in the brain and physiological and toxic effects.
This document summarizes the history and effects of amphetamines. It was first synthesized in 1887 but not used medically until 1934 as a decongestant. During World War II, amphetamines were used for their stimulant and performance-enhancing effects. Amphetamines work by increasing the neurotransmitters dopamine, serotonin, and norepinephrine. They can produce both helpful effects like happiness and energy, as well as harmful effects like addiction, aggression, and overdose risks. While they have therapeutic uses, amphetamines also carry misuse risks if used illegally or without medical supervision.
Hallucinogens, also known as psychedelic drugs, alter perception and can cause hallucinations. Some examples include LSD, DMT, PCP, and marijuana. Albert Hofmann first synthesized LSD in 1938, and hallucinogenic mushrooms have been used for thousands of years for religious or medicinal purposes by ancient cultures. While some advocate for medical uses, hallucinogens are currently illegal and can have harmful physical, emotional, and social effects if abused.
CNS stimulants are psychoactive drugs that can temporarily improve mental or physical function. They have medical uses like treating ADHD, narcolepsy, obesity, and depression. There are two types - psychomotor stimulants and hallucinogens. Psychomotor stimulants cause excitement and decrease fatigue while hallucinogens produce profound changes in thought patterns. Common psychomotor stimulants include caffeine, nicotine, amphetamines, cocaine, and methylphenidate which are used to treat various conditions. Hallucinogens include LSD and THC. CNS stimulant addiction can cause health issues and problems in relationships, work, and daily life.
The document provides information about various hallucinogenic drugs like PCP, LSD, and ecstasy. It discusses the pharmacological effects of these drugs on the brain and body. It also covers the potential symptoms of toxicity and overdose from hallucinogen use as well as myths and rumors surrounding these drugs. The goal is to educate students about hallucinogens and their consequences in order to help students make informed choices.
This document discusses hallucinogenic drugs. It defines different terms used to describe hallucinogens and describes the two main classes of hallucinogens - classical phantastica and deliriants. It focuses on LSD, describing its discovery, early uses, advocates like Timothy Leary, effects, and debates around its medical and therapeutic use. The document also briefly profiles several other common hallucinogenic plants and substances.
This document discusses drug abuse and its effects. It defines drugs as substances that alter mental or physical states, and distinguishes between medical and recreational uses. Commonly abused drugs are listed, including marijuana, methamphetamine, and cocaine. The document notes that drug addiction involves psychological and physical dependence, and impacts individuals through aggressive behavior and health issues, families through relationship and financial problems, and society through lost productivity and crime. Treatment involves pharmacological, social, and legal approaches, as well as family support.
This document summarizes different types of central nervous system (CNS) stimulants. It describes convulsants like strychnine that act by inhibiting the inhibitory neurotransmitter glycine. It also discusses analeptics like doxapram that stimulate respiration. Psychomotor stimulants such as amphetamines are described as producing excitement, euphoria and increased motor activity by blocking neurotransmitter reuptake or promoting release. Hallucinogens can induce changes in thought patterns and mood. The document provides examples and mechanisms of action for various classes of CNS stimulant drugs.
This document discusses poisoning from central nervous system stimulants like amphetamines and cocaine. It provides details on amphetamine poisoning including its mode of action, signs and symptoms, fatal dose, treatment, and post-mortem findings. For cocaine poisoning, it similarly outlines its introduction, routes of administration, mode of action, acute signs and symptoms, fatal dose, diagnosis, treatment, and post-mortem appearances. It also discusses chronic cocaine poisoning and its associated signs and symptoms.
This document discusses various commonly abused substances including amphetamines, cocaine, MDMA, synthetic cathinones, LSD, marijuana, synthetic cannabinoids, ethanol, and prescription drugs. It describes their mechanisms of action, effects, routes of administration, toxicity, and medical management for overdoses. Drug abuse is a serious public health issue and substances have become more potent and addictive over time.
Reviews the uses for benzodiazepines and barbiturates, the signs of intoxication and withdrawal, impact on sports performance. Continuing Education for mental health and substance abuse counselors and therapists.
Central nervous system (CNS) depressants are a class of drugs that slow down brain activity and cause muscles to relax. They include benzodiazepines, barbiturates, alcohol, opioids, and some sleeping pills. They work by enhancing the effects of the inhibitory neurotransmitter GABA at GABAA receptors in the brain, resulting in sedative, hypnotic, anxiolytic, and muscle relaxant effects. While effective for treating conditions like anxiety and insomnia, long-term use can lead to tolerance, addiction, and withdrawal symptoms.
This document provides information on various drugs and their effects. It discusses stimulants like caffeine, nicotine, and cocaine which speed up the nervous system, as well as depressants like alcohol and heroin which slow it down. Hallucinogens like LSD and ecstasy are described as altering a user's state of consciousness. Specific drugs like alcohol, marijuana, ecstasy, rohypnol, heroin, cocaine, and crystal meth are then outlined, with details of their methods of use, short and long term impacts on physical and mental health, and risks of addiction. The document concludes by discussing the societal effects of substance abuse like increased disease transmission and crime.
This document discusses the neurobiology of addiction. It provides an overview of neurotransmission, including action potentials, the neurotransmitter lifecycle, and receptor types. Specific neurotransmitters are examined, such as dopamine, GABA, glutamate, and opioids. The roles of these neurotransmitters in addiction and how various drugs affect neurotransmitter systems are described. Genetic and environmental factors that can contribute to addiction are also reviewed.
Stimulants work by blocking monoamine transporters like dopamine, increasing their levels in the brain. This can cause both acute effects like euphoria but also chronic addiction through changes in brain regions involved in reward. Management of acute intoxication focuses on stabilization while withdrawal typically resolves in 2 weeks with supportive care. Relapse prevention requires comprehensive psychosocial treatment though some medications may help reduce cocaine use.
Pharmacology document discusses central nervous system (CNS) depressants like alcohols, barbiturates, benzodiazepines, and newer non-benzodiazepine hypnotics. It describes their mechanisms of action, pharmacological effects on various body systems, classifications, and examples. Key points include ethanol and methanol acting as CNS depressants; barbiturates formerly used as hypnotics and sedatives but now replaced due to side effects; benzodiazepines having lower CNS depression than barbiturates; and newer non-benzodiazepine hypnotics like zolpidem and zaleplon acting on GABA receptors with improved
The document discusses inhalants, which are substances like solvents, aerosols, gases, and nitrites that are inhaled to get high. Over 2.6 million youth between 12-17 abuse inhalants each year, making them the fourth most abused substance. Inhalant use often begins before age 12 and can cause immediate effects like dizziness or death from sudden sniffing death syndrome. Long term effects include brain, liver, and kidney damage. Education is key to preventing inhalant abuse.
Inhalants are toxic vapors from substances like cleaning products and paint thinner that slow the body's functions. Short term effects include slurred speech, dizziness, and hallucinations. Long term use can cause muscle weakness, brain damage, and heart or lung damage. Repeated inhalation can cause sudden death from heart failure within minutes, called sudden sniffing death. Younger children abuse inhalants more than older children, and signs of abuse include red nose and loss of appetite.
Inhalants can be categorized into four groups: volatile hydrocarbons found in items like gasoline and paint thinners, aerosols found in sprays like hairspray and vegetable oil spray, nitrates like poppers, and gases like nitrous oxide. Inhalants are commonly abused by adolescents between 12-16 years old and can cause intoxication within a minute of inhalation. Chronic inhalant use can lead to tolerance, organ damage, and death from cardiac arrhythmias or respiratory failure due to the drugs' effects on inhibitory GABA and excitatory glutamate receptors in the brain.
This document provides an overview of the pharmacology of alcohol (ethanol). It discusses the absorption, distribution, metabolism and elimination of alcohol. It describes genetic factors that influence these processes and gender differences in responses. The document also reviews the central nervous system effects of alcohol including intoxication, tolerance development and mechanisms of action. Finally, it outlines some of the organ-specific pharmacological and pathological effects of both acute and chronic alcohol use.
The document discusses inhalants, including their scientific and street names, how they are abused through huffing or sniffing, signs of abuse like smelling clothes or markers near the nose, and resources for help with inhalant abuse in Washington state. It also describes an educational board game about inhalant abuse where students role a die and their health points are affected depending on the color space landed on, with consequences for abusing inhalants or staying safe.
This document discusses the toxicity of ethanol and methanol. Ethanol is commonly used as an alcohol ingredient but can cause intoxication in high amounts by depressing the central nervous system. Methanol is toxic and can cause blindness or death when metabolized into formic acid. Both ethanol and methanol are absorbed quickly and metabolized in the liver, with their toxicity resulting from metabolic byproducts. Proper diagnosis and treatment is needed for methanol poisoning due to its delayed onset and serious complications.
Glass forms radial cracks from the point of impact spreading outwards. Concentric cracks form perpendicular to the front surface where the blow lands. By examining the direction of stress lines on the cracks, one can determine which side the glass was broken from. Comparing glass fragments found at a crime scene to a vehicle can help identify hit and run vehicles or determine if glass was broken from inside or outside in robbery cases.
The document discusses the history and uses of narcotics. It describes how narcotics have been used for centuries to relieve pain and alter moods. It outlines various methods of taking narcotics including orally, injection, smoking and patches. The document also covers street names for narcotics, classifications of narcotics by schedule, and both the medical and non-medical uses as well as various physical, mental, social and legal effects of narcotic use.
Methamphetamine is a highly addictive psychostimulant that affects the central nervous system. It causes the release of neurotransmitters like dopamine and activates the cardiovascular and nervous systems. While it is prescribed to treat conditions like ADHD and obesity in limited cases under the brand name Desoxyn, methamphetamine is more commonly abused as an illegal street drug known as "ice" or "crystal" that produces feelings of euphoria. Long term meth abuse is associated with severe health risks and addiction.
Nitrous oxide injection systems work by injecting nitrous oxide gas into the engine's intake manifold, allowing for more oxygen and thus higher combustion of fuel, increasing horsepower. There are wet and dry nitrous systems that inject nitrous oxide along with fuel or separately. While nitrous provides a powerful boost, it also puts stress on engine components, so reliability is a concern without properly tuning the fuel-air ratio. The use of nitrous oxide in vehicles is illegal for street use in some jurisdictions due to emissions and insurance implications.
General anesthetics act by modifying the electrical activity of neurons at a molecular level through effects on ion channels. The most widely accepted theory is that they bind directly to ion channels or disrupt proteins that maintain channel function. Common intravenous anesthetics like propofol and benzodiazepines enhance the effects of the inhibitory neurotransmitter GABA. They produce dose-dependent decreases in heart rate, blood pressure and respiratory function.
This document discusses opioids and narcotics, including:
1. It defines opioids, opiates, and narcotics and lists some common synthetic prescription narcotics like oxycodone, hydrocodone, and fentanyl.
2. It describes the medical uses of narcotics for pain relief and treating intestinal disorders, while also outlining both the physical and emotional effects of narcotic use.
3. It discusses the risks of dependency and toxicity that can arise from chronic narcotic use, including infections from shared needles and respiratory depression. Withdrawal symptoms are also detailed.
The document discusses several key aspects of pharmacology and drug actions in the human body. It defines pharmacology as the interaction between drugs and living organisms. It describes how drugs are administered, absorbed, distributed, metabolized and excreted in the body. It then discusses how drugs can affect the nervous system, including the central nervous system, autonomic nervous system and peripheral nervous system. It provides details on the different neurotransmitters like dopamine, acetylcholine, norepinephrine, serotonin, GABA, glutamate and endorphins. It explains the lifecycle of neurotransmitters and how drugs can alter their availability. Other topics covered include drug classifications, dose-response relationships, routes of drug administration, and concepts of tolerance
This document summarizes the history of drug laws in the United States from the 1700s to present day. It discusses how the first drugs regulated were alcohol and opium, and laws gradually expanded to include other substances like cocaine and marijuana. Major legislation over time aimed to tax drugs, require prescriptions, define schedules of controlled substances, and strengthen FDA oversight of new drugs. Debates continue around decriminalization, legalization, harm reduction strategies, and disproportionate impacts on minorities.
This document discusses sedative-hypnotic drugs, which are central nervous system depressants that produce relaxing to sleep-inducing effects. It covers different types of sedative-hypnotic drugs like barbiturates, benzodiazepines, and non-benzodiazepine hypnotics. It also discusses their medical uses, mechanisms of action, dangers of abuse and overdose, and risks of dependence and withdrawal.
This document contains information about stimulant drugs presented in a classroom format. It discusses the history of cocaine and its use as a local anesthetic. It also covers the mechanisms of action and effects of stimulants like cocaine and amphetamines. Additionally, it addresses the use of stimulant medications like Ritalin and Adderall to treat ADD/ADHD, including benefits, risks, and considerations around prescribing to children. The document also includes sections on caffeine as a drug, its sources, pharmacology, and effects, as well as perspectives on its consumption and potential age limits.
This document summarizes key information about narcotics and opioids from Chapter 8 of the textbook Drugs & Society. It discusses the medical uses of opioids like morphine and codeine, as well as recreational drugs derived from opium like heroin and oxycodone. It also covers the physical, emotional, and social effects of opioid use, dependency and withdrawal symptoms, treatment options using drugs like methadone and suboxone, and harm reduction strategies like needle exchange programs.
This document discusses the social costs and consequences of drug use in society. It notes that drug use can result in deaths, emergency room visits, lost productivity, broken homes, shorter lifespans and higher medical costs. Specific data is provided on drug use rates in the US from national surveys. The impacts of drug use on the family, social behavior, education, employment and pregnancy are explored. Different patterns of drug use and the changing views on dependence and addiction are also summarized.
CNS depressants like benzodiazepines and barbiturates are commonly prescribed but can cause problems if not properly monitored. Their use began in the 1800s with bromides and was later replaced by barbiturates and then benzodiazepines. While relatively safe in short term use, long term use of benzodiazepines can lead to dependence and withdrawal problems. CNS depressants work by reducing brain activity and awareness through effects on the neurotransmitter GABA. They are classified based on their effects from sedatives to hypnotics to anesthetics depending on dose.
Central nervous system (CNS) depressants are drugs that reduce nervousness, excitability, and irritability without causing sleep at low doses, or that cause sleep at high doses. There are two main types: sedatives, which calm the CNS, and hypnotics, which induce sleep. Common sedative-hypnotics are barbiturates and benzodiazepines. Barbiturates have a narrow therapeutic index and can cause respiratory depression in overdose. Benzodiazepines are more commonly prescribed due to their favorable side effects, efficacy, and safety compared to barbiturates. Nursing implications for CNS depressants include monitoring for side effects and ensuring patient safety.
Central nervous system (CNS) depressants are drugs that reduce nervousness, excitability, and irritability without causing sleep at low doses, or that cause sleep at high doses. There are two main types: sedatives, which calm the CNS, and hypnotics, which induce sleep. Common sedative-hypnotics are barbiturates and benzodiazepines. Barbiturates have a narrow therapeutic index and can cause respiratory depression in overdose. Benzodiazepines are more commonly prescribed due to their favorable side effects, efficacy, and safety compared to barbiturates. Nursing implications for CNS depressants include monitoring for side effects and ensuring patient safety.
Central nervous system (CNS) depressants are drugs that reduce nervousness, excitability, and irritability without causing sleep. They include sedatives and hypnotics. Sedatives calm the CNS without inducing sleep, while hypnotics calm the CNS enough to cause sleep. Barbiturates were commonly used as sedative-hypnotics but have been replaced by benzodiazepines, which have more favorable side effects and safety profiles. Both can cause drowsiness, respiratory depression, and interactions with other CNS depressants like alcohol. Nurses must monitor patients taking these drugs for therapeutic effects and side effects.
Sedatives and hypnotics are central nervous system depressants that can calm or soothe the nervous system. Sedatives reduce nervousness and irritability without causing sleep, while hypnotics cause sleep. Sedative-hypnotics can have sedative effects at low doses and hypnotic effects at high doses. Barbiturates were commonly used as sedative-hypnotics but have been replaced in large part by benzodiazepines due to safety and efficacy concerns. Both classes work by inhibiting activity in the brain stem and cerebral cortex.
Barbiturates are one of the much oldest classes of sedative-hypnotic agents. They have typically significant depressive cardiovascular and respiratory effects, however, and have been largely replaced in the ICU by the benzodiazepines, propofol, butyrophenones, and other newer agents. Barbiturates are occasionally availed for deep sedation or anesthesia in mechanically ventilated patients with status epilepticus and in patients with quiet elevated intracranial pressure (barbiturate coma). In patients with closed-head injury and aggrandized intracranial pressure refractory to conventional therapies, survival has been improved by adding high-dose barbiturates to conventional therapy Barbiturate, any of a class of organic compounds availed in medicine as sedatives (to produce a calming effect), as hypnotics (to produce sleep), or as an adjunct in anesthesia. Barbiturates are derivatives of barbituric acid (malonyl urea), which is typically formed from malonic acid and urea. Barbital was first synthesized in 1903, and phenobarbital became available in 1912. Barbiturates act by depressing the central nervous system, specifically on certain portions of the brain, though they tend to depress the functioning of all the body’s tissues. Most of them exert a quiet sedative effect in small doses and a hypnotic effect in larger doses [2]. The barbiturates have largely been replaced as sedatives by the benzodiazepines and other minor tranquilizers, which have fewer unfavourable side effects and less abuse potential.
Sedative hypnotics like barbiturates act as central nervous system depressants, inducing sedation, hypnosis, and anesthesia. They have therapeutic uses for anxiety, insomnia, and seizures but also carry risks of dependence and withdrawal symptoms. Nursing management focuses on monitoring for side effects like drowsiness, orthostatic hypotension, and paradoxical reactions while educating patients on safe use, dependence risks, and avoiding alcohol and other CNS depressants.
This document discusses sedative-hypnotic drugs, including their classification, medical uses, and dangers. It covers three main types - barbiturates, nonbarbiturate sedatives, and benzodiazepines. While they can be used to treat anxiety, insomnia, and seizures, they carry risks of dependence, withdrawal, and toxicity when taken in large doses or combined with alcohol.
Chapter 4 Pharmacology Diploma in Pharmacy Part -1 .pdfSumit Tiwari
Drugs Acting on the Central Nervous System
Definition, classification, pharmacological actions, dose,
indications, and contraindications of
General anaesthetics
Hypnotics and sedatives
Anti-Convulsant drugs
Anti-anxiety drugs
Anti-depressant drugs
This document defines and describes substance-related disorders and the main categories of substances that can cause them. It notes that substance use disorders include abuse and dependence, while substance-induced disorders involve intoxication, withdrawal, and mental states induced by the substance. It then provides details on depressants, stimulants, and hallucinogens - the main classes of substances that can cause these disorders. It defines each category and provides examples of substances that fall within them, along with their effects and medical/recreational uses.
The document discusses central nervous system (CNS) depressants, including their history, effects, types, medical uses, and dangers of abuse. Some key points include: CNS depressants such as benzodiazepines and barbiturates were developed to treat conditions like anxiety, insomnia, and seizures. They work by enhancing the effects of the inhibitory neurotransmitter GABA. While usually prescribed medications, they can cause dependence and dangerous interactions if misused or abused. Long-term trends show a decline in barbiturate use due to safety issues, being replaced primarily by benzodiazepines which have a wider therapeutic margin.
This document discusses anti-anxiety drugs, including their classification, mechanisms of action, indications, and nursing considerations. It describes how anxiety results from an imbalance of chemicals in the brain and how anti-anxiety medications work by potentiating GABA receptors. Major drug classes covered are barbiturates, benzodiazepines, and non-benzodiazepines. Common drugs discussed are diazepam, midazolam, phenobarbital, and choral hydrate. Indications, dosages, routes of administration, side effects, nursing implications, and patient education are summarized for safe and effective use of these medications.
This document discusses sedatives and hypnotics which are drugs that depress the central nervous system. Sedatives are used to treat anxiety while hypnotics cause sleep. Both can lead to tolerance and dependence with long term use. The document categorizes and describes different types of sedatives and hypnotics like barbiturates, benzodiazepines, and other drugs. It provides information on their uses, side effects, and important considerations for administration.
This document discusses sedative-hypnotic drugs, which are central nervous system depressants that produce relaxing to sleep-inducing effects. It describes three main types - barbiturates, nonbarbiturate sedatives, and minor tranquilizers. The document also discusses the medical uses of these drugs to treat anxiety, insomnia, and seizures, as well as the risks of dependence, withdrawal, toxicity, and fatal interactions with alcohol.
Sedatives, hypnotics, affective and antipsychotic medications for odla exercisedanielriddick
The document discusses sedative-hypnotic and antianxiety drugs, antidepressants, bipolar drugs, and antipsychotics. It covers the major drug classes in each category, their mechanisms of action, effects, side effects, and implications for physical therapy management of patients taking these medications. The learning objectives focus on understanding the pharmacology, recognizing signs and symptoms, modifying physical therapy approaches, and addressing patient safety concerns.
This document discusses anxiolytics, or anti-anxiety drugs. It defines anxiety and differentiates it from fear. It outlines the learning objectives which are to define key terms, list classes of anxiolytic drugs, and describe the mechanisms of action, effects, pharmacokinetics, adverse effects, and interactions of anxiolytics. The major classes of anxiolytics discussed are benzodiazepines, azapirones, and beta-blockers. Benzodiazepines are described as the most important sedative-hypnotics, with properties including a wide margin of safety but risk of dependence with prolonged use. Buspirone is discussed as an azapirone anxi
Hello friends. In this PPT I am talking about CNS drugs. If you like it, please do let me know in the comments section. A single word of appreciation from you will encourage me to make more of such videos. Thanks. Enjoy and welcome to the beautiful world of pharmacology where pharmacology comes to life. This video is intended for MBBS, BDS, paramedical and any person who wishes to have a basic understanding of the subject in the simplest way.
Sedative-hypnotic drugs reduce anxiety and induce sleep by depressing activity in the central nervous system. The main classes are benzodiazepines, barbiturates, and newer non-benzodiazepine agents. Benzodiazepines have largely replaced barbiturates due to their wider therapeutic index, lower risk of interactions and dependence, and the availability of antagonists. Both benzodiazepines and barbiturates work by enhancing the effects of the inhibitory neurotransmitter GABA.
This document discusses sensory disabilities related to hearing and vision loss. It covers the changing experiences of people with these disabilities since special education laws were passed. It also defines and classifies different types of hearing and vision loss, describes their characteristics and prevalence. The document outlines causes and risk factors, assessment procedures, and interventions from early childhood through adulthood for children with sensory disabilities.
This document discusses severe and multiple disabilities, including definitions, characteristics, causes, assessment, and interventions from early childhood through adulthood. It describes how the lives of those with severe disabilities have changed since IDEA, and outlines interventions and supports to help them develop skills and participate inclusively in school and community life. The goal is for those with severe disabilities to lead happy, productive lives.
This document outlines the key points of a chapter about autism spectrum disorders (ASD). It discusses:
1) How understanding and support for people with ASD has improved since special education laws were passed.
2) The various definitions and classifications of ASD.
3) The characteristics of ASD including difficulties with social skills and repetitive behaviors, as well as strengths like savant skills.
4) Potential causes of ASD and the multifactorial nature of its origins.
This document outlines the learning objectives for Chapter 10 which covers communication disorders. It discusses the changes in lives of people with communication disorders since IDEA, typical communication development processes, and various communication disorders including their definitions, prevalence, causes, identification and interventions. Specific disorders covered include language disorders, speech sound disorders, child onset fluency disorder, social communication disorder, and voice and resonance disorders.
This document outlines the key learning objectives and content covered in Chapter Nine, which examines intellectual and developmental disabilities. The chapter discusses how the lives of those with intellectual disabilities have changed since special education laws were passed, provides definitions and classifications of intellectual disabilities, and describes characteristics, causes, assessments, and interventions from early childhood through adulthood. It emphasizes that individuals with intellectual disabilities can achieve autonomy and independence with appropriate long-term supports.
The document describes gifted, creative, and talented individuals and their education. It covers:
1) Definitions of giftedness have changed from IQ to multiple measures including creativity and talent. 2) 2-5% of students are typically identified as gifted, increasing to 10-25% in special programs.
3) Identification methods include teacher nomination, intelligence/achievement tests, and creativity tests. Interventions include early education programs, differentiated learning, acceleration, and addressing needs of underrepresented groups.
This document outlines the key learning objectives and content covered in Chapter Nine, which examines intellectual and developmental disabilities. The chapter describes how the lives of those with intellectual disabilities have changed since protections like IDEA were established. It defines intellectual disability, exploring factors like IQ, adaptive behaviors, and age of onset. It also looks at prevalence rates, potential causes, assessment procedures, and interventions from early childhood through adulthood to support independence.
The chapter discusses emotional and behavioral disorders (EBD) and interventions for children with EBD. It covers definitions of EBD, characteristics and prevalence, causes and risk factors, assessment procedures, and interventions from early childhood through adulthood. These include positive behavior support, response to intervention, functional behavior assessments, and wraparound services. The chapter emphasizes evidence-based practices, systems of care, early intervention, and school-wide behavior support to help children with EBD achieve better outcomes.
This document discusses learning disabilities (LD), including:
1) It provides an overview of definitions and classifications of LD according to IDEA, including that LD are neurological disorders that affect areas like reading, writing, and math.
2) It describes the characteristics of individuals with LD, including challenges with academic achievement, intelligence, perception, and social/emotional skills.
3) It discusses interventions and support for individuals with LD throughout development from elementary school through adulthood.
This document outlines learning objectives for a chapter that describes various physical disabilities and health disorders. It discusses 13 objectives that will cover conditions such as cerebral palsy, spina bifida, spinal cord injury, muscular dystrophy, HIV/AIDS, asthma, epilepsy, diabetes, cystic fibrosis, sickle cell disease, traumatic brain injury, and attention deficit hyperactivity disorder. For each objective, the document will describe the prevalence and causation of the condition and interventions.
The document discusses drug abuse prevention and approaches, including how serious the problem of drug dependence is in the US with an estimated 20.6 million people classified with substance dependence or abuse. It covers goals and levels of prevention programs from primary to tertiary, as well as strategies, examples of programs, and ways to make drug education more effective, such as establishing links between messages and students' lives.
The document discusses various topics related to marijuana, including:
1. The history of marijuana use and its changing perceptions over time, from its medicinal uses in early colonial times to the criminalization of marijuana in the 1900s.
2. The physiological and psychological effects of marijuana, including its effects on the cardiovascular, pulmonary and central nervous systems. It also covers tolerance and withdrawal.
3. Current debates around marijuana, including its medical uses, toxicity, and changing public attitudes toward legalization.
This document discusses hallucinogenic drugs. It begins by providing survey results about hallucinogen use. It then discusses terms used to describe hallucinogens and classes them. It provides details about specific hallucinogenic drugs like LSD, psilocybin, DMT and others. It discusses the history of use of these drugs, their effects both beneficial and adverse, and debates around therapeutic vs recreational use.
This document provides information on stimulant drugs including cocaine, amphetamines, and caffeine. It discusses the history, mechanisms of action, effects, and risks of these substances. Key points include:
- Cocaine was historically used as a local anesthetic but is now illegal due to its high risk of addiction and health effects. It blocks the reuptake of dopamine and serotonin.
- Amphetamines were originally used to combat fatigue but are now regulated due to risks of dependence and toxicity. They stimulate the release of monoamine neurotransmitters like dopamine.
- Caffeine is found in coffee, tea, soda, and other products. It acts by blocking adenosine receptors and produces mild
This document provides information about opioids (narcotics) from a class on drugs and society. It discusses various opioids like heroin, morphine, and codeine. It covers topics like opioid abuse patterns in the US, methods of opioid administration, physical and psychological effects of opioids, dependency and withdrawal. The document also discusses medical uses of opioids and harm reduction strategies like needle exchange programs and medications like suboxone and methadone to help treat opioid addiction.
This document summarizes key topics related to alcohol including:
1. The pharmacology of alcohol including how it is absorbed in the body and metabolized in the liver. Alcohol primarily impacts the limbic system part of the brain.
2. The behavioral effects of different blood alcohol content levels and types of alcoholism. Alcoholism is considered by some to have genetic and psychosocial risk factors.
3. The impacts of alcoholism on families including increased risks for children of alcoholics developing alcoholism or other disorders themselves. Family roles that sometimes develop in alcoholic families are also outlined.
4. The social costs of alcoholism including increased risks of violence, suicide, and accidents when alcohol is involved. W
This document discusses how drugs work and their intended and unintended effects. It explains that intended responses are the reason for using the drug, while unintended responses like side effects are unexpected. Common side effects include nausea, changes in alertness, dependence, withdrawal, and allergic reactions. The dose and method of administration can impact effects. Drugs are distributed throughout the body and metabolized at different rates depending on their properties. Factors like tolerance and interactions with other drugs also influence drug responses.
This document discusses how drugs work and their intended and unintended effects. It explains that intended responses are the reason for using the drug, while unintended responses are side effects. Common side effects include nausea, changes in alertness, dependence, withdrawal, and allergic reactions. The dose and route of administration, as well as individual factors like age, gender, and metabolism influence a drug's effects. Long-term drug use can lead to tolerance, dependence, addiction, and abuse.
This document provides an overview of homeostatic systems and drugs. It discusses the nervous system and endocrine system, which work together to maintain homeostasis. The nervous system consists of neurons that send and receive electrochemical signals via neurotransmitters. Common neurotransmitters like dopamine and serotonin are described. The central nervous system structures like the brain and spinal cord are covered as well as the peripheral and autonomic nervous systems. The endocrine system is introduced as a second messenger system using hormones to regulate bodily functions. Anabolic steroids are discussed as a hormone that is sometimes abused.
The document discusses the history of drug regulation laws in the United States from the early 1900s to present day. It covers major acts and amendments that aimed to regulate drugs and drug development, including the 1906 Pure Food and Drug Act, Harrison Act of 1914, 1970 Controlled Substances Act, and Kefauver-Harris Amendments. The "War on Drugs" of the 1980s is also summarized, which took a criminal justice approach to drug abuse. Prevention strategies discussed include supply reduction, demand reduction, and harm reduction approaches.
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
A workshop hosted by the South African Journal of Science aimed at postgraduate students and early career researchers with little or no experience in writing and publishing journal articles.
How to Setup Warehouse & Location in Odoo 17 InventoryCeline George
In this slide, we'll explore how to set up warehouses and locations in Odoo 17 Inventory. This will help us manage our stock effectively, track inventory levels, and streamline warehouse operations.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPRAHUL
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
Leveraging Generative AI to Drive Nonprofit InnovationTechSoup
In this webinar, participants learned how to utilize Generative AI to streamline operations and elevate member engagement. Amazon Web Service experts provided a customer specific use cases and dived into low/no-code tools that are quick and easy to deploy through Amazon Web Service (AWS.)
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
2. Introduction to CNS
Depressants
Why are CNS depressants problematic?
◦Usually prescribed under physician’s direction
◦Second most frequently abused prescription
drug and sometimes contributes to death due to
accidental overdoses
◦Can cause very alarming and dangerous
behavior if not closely monitored
◦ Most problems associated with these drugs
due to inadequate professional supervision
3. Introduction to CNS Depressants
(continued)
Why are CNS depressants problematic?
◦Seemingly unrelated drug groups can cause
CNS depression
◦Combination use can cause dangerous drug
interactions
◦Can cause disruptive personality changes
4. The History of CNS
Depressants
Attempts to find CNS depressants other than alcohol began in the 1800s.
Bromides were introduced to treat nervousness and anxiety in the 1800s.
◦Very popular but toxic
In the early 1900s, bromides were replaced by barbiturates.
◦Initially heralded as safe and effective
◦Apparent problems with tolerance, dependence,
and safety
5. The History of CNS Depressants
(continued)
In the 1950s the first benzodiazepines were marketed as substitutes for
barbiturates.
◦Relatively safe when used for short periods
◦Long-term use can cause dependence and
withdrawal problems
6. The History of CNS Depressants
(continued)
Benzodiazepines were routinely prescribed for stress, anxiety, or apprehension.
◦In 1973, 100 million prescriptions were written
for benzodiazepines.
◦Twice as many women as men taking them.
As medical community became aware of the problem, use of depressants declined,
but benzodiazepines remained still very popular.
Classified as Schedule V drugs
7. The Effects of CNS
Depressants
CNS depressants reduce CNS activity and diminish the brain’s level of
awareness.
Depressant drugs include:
◦ Benzodiazepines
◦ Barbiturate-like drugs
◦ Alcohol
◦ Antihistamines
◦ Opioid narcotics like heroin
8. Sedative-Hypnotic Drugs (depressants)
Drugs that slow activity in the central nervous system
Include prescription drugs
◦ To treat anxiety: sedatives
◦ To treat insomnia: hypnotics
Alcohol is the most widely used depressant
Benzodiazepines are the most widely prescribed depressants
9. The Effects of CNS Depressants
(continued)
Depressants are usually classified according to the degree of their medical
effects on the body. For example:
◦Sedatives cause mild depression and relaxation
◦Anxiolytic—drugs that relieve anxiety
◦Hypnotics induce drowsiness and encourage
sleep
◦ Amnesiac effects can cause the loss of
memory
10. The Effects of CNS Depressants
(continued)
The same drug can cause different effects depending on dose.
◦Low dose (sedatives—relieve anxiety and
promote relaxation)
◦Higher doses (hypnotics—can cause
drowsiness and promote sleep)
◦Even higher doses (anesthetics can cause
anesthesia and are used for patient
management during surgery)
11. EffectsProduce a depressed, mood-altering action on the central nervous system
– act on GABA
Slow activity of the cardiovascular, muscular and respiratory systems
Can cause confusion, inadequate emotional control, slurred speech, poor
judgment, and intoxication
12. Types of CNS Depressants
Benzodiazepines: Valium-Type Drugs
◦ Prescribed for anxiety, relaxation and sleep
Medical uses
◦ Relief from anxiety, treatment of neurosis,
relaxation of muscles, alleviation of lower-back
pain, treatment of convulsive disorders,
induction of sleep, relief from withdrawal
symptoms, induction of amnesia
13. Types of CNS Depressants
(continued)
Mechanisms of action for benzodiazepine
◦Affect neurons that have receptors for the
neurotransmitter GABA
GABA: most common inhibitory transmitter in brain regions
◦ Limbic system (alter mood)
◦ RAS (cause drowsiness)
◦ Motor cortex (relax muscles)
14. Types of CNS Depressants
(continued)
Types of benzodiazepines
◦Many benzodiazepine compounds available in
the United States
◦Distinguished primarily by their duration of
action: short-acting (hypnotics), long-acting
(sedatives)
Side effects include drowsiness to paradoxical effects (e.g. increased
restlessness), tolerance, dependence, withdrawal, and abuse
15. Types of CNS Depressants
(continued)
Barbiturates played an important historical role as sedative-hypnotic agents.
However, due to their narrow margin of safety and their abuse liability, they
were replaced by benzodiazepines.
◦Caused many negative side effects, from
nausea to death, from respiratory or
cardiovascular depression
16. Other Types of CNS
Depressants
Drugs with barbiturate-like properties:
◦Chloral hydrate
◦Glutethimide
◦Methyprylon
◦Methaqualone
Antihistamines
Propofol (abused general anesthetic)
GHB (gamma hydroxybutyrate)
17. Medical Uses
Used primarily to treat
◦Anxiety
◦Insomnia
◦Convulsive disorders
Short-acting barbiturates continue to
be used for anesthetic purposes
18. Mechanisms of Action
Benzodiazepines and
barbiturates
◦Enhance inhibitory effects of GABA
Non-benzodiazepine hypnotics
◦Selectively target the GABA-A receptor
◦Work better as sleep aids rather than anti-anxiety
medications
◦Zolpidem (Ambien), zaleplon (Sonata), eszopiclone
(Lunesta)
19. Medical uses for barbiturates
do NOT include:
A. Treating depression
B. Reducing anxiety
C. Controlling seizures
D. Inducing sleep
Treatingdepression
Reducing
anxietyControllingseizures
Inducingsleep
57%
22%22%
0%
21. In comparison to barbiturates,
benzodiazepines
A. Have more severe
side effects
B. Are not addictive
C. Do not cause
withdrawal
symptoms
D. Have a wider safety
margin
Havem
oresevere
sideef...Are
notaddictive
Do
notcause
w
ithdraw
al...
Havea
w
idersafety
m
argin
4%
87%
0%
9%
22. Patterns of Abuse
with CNS Depressants
The American Psychiatric Association considers dependence on CNS
depressants a psychiatric disorder.
23. Patterns of Abuse with CNS
Depressants (continued)
People most likely to abuse CNS depressants include individuals who:
◦Use drugs to relieve continual stress
◦Paradoxically feel euphoria and stimulation
from depressants
◦Use depressants to counteract the unpleasant
effects of other drugs of abuse
◦Combine depressants with alcohol and heroin
to potentiate the effects
24. Patterns of Abuse with CNS
Depressants (continued)
Detoxification: The elimination of a toxic substance, such as a drug, and its
effects
◦With CNS depressants, this is achieved by
substituting a longer-acting barbiturate for the
offending CNS depressant and gradually reducing
the dose to avoid unpleasant withdrawal effects.
Withdrawal from CNS depressants, if not
managed properly, can be very dangerous, or
even fatal.
25. Do you know someone who has had
their drink spiked with GHB or roofies?
A. I think so
B. I don’t think so
Ithinkso
Idon’tthinkso
54%
46%
26. Do you know someone who has
drugged someone else by spiking their
drink?
A. I think so
B. I don’t think so
Ithinkso
Idon’tthinkso
75%
25%
27. Gamma Hydroxybutyric
Acid
Naturally occurring chemical found in brain and body
Similar to GABA
Causes CNS depression
Has been used as an anesthetic
Considered a date-rape drug
◦ Along with Rohypnol and Ketamine
GHB is listed on Schedule I
https://www.youtube.com/watch?v=LPtcU_8yvR4
https://www.youtube.com/watch?v=YwtBEkFXBjQ
https://www.youtube.com/watch?v=2udrpuNxcmM
28. When it is used in
conjunction with alcohol,
the effects of Rohypnol
can be fatal.
A. True
B. False
True
False
8%
92%
30. Introduction
Volatile substances introduced via the lungs.
Most cause intoxicating and/or euphorigenic
effects.
Many of these substances were never intended
to be used by humans as drugs; consequently,
they are not often thought of as having abuse
potential.
31. Inhalants are among the most commonly used
drugs by adolescents.
A widespread misconception is that inhalant
abuse is a harmless phase that occurs
commonly during normal childhood and
teenage development and as such is not
worthy of significant concern.
Introduction (continued)
32. Potential Consequences
“Sudden Sniffing Death Syndrome” (SSDS): A
condition characterized by serious cardiac
arrhythmia occurring during or immediately after
inhaling
Brain damage
Damage to heart, kidney, liver, and bone marrow
33. History
In 1776, British chemist Joseph Priestley
synthesized nitrous oxide, a colorless gas with a
slightly sweet odor and no noticeable taste.
Priestly and Humphry Davy suggested correctly
that the gas might be useful as an anesthetic, and
experiments were conducted to test this
possibility.
34. Legislation
Inhalants are generally not regulated as are
other drugs of abuse.
Some states have adopted laws preventing the
use, sale, and/or distribution to minors of
various products abused commonly as
inhalants.
36. Volatile Substances
Includes aerosols, art or office supplies,
adhesives, fuels, and industrial or household
solvents.
Some abusers inhale vapors directly from their
original containers (called sniffing or snorting).
Some abusers inhale volatile solvents from plastic
bags (called bagging) or from old rags or
bandannas soaked in the solvent fluid and held
over the mouth (called huffing).
37. Potential Effects of Inhaling
Volatile Substances
Can cause irritation of airways causing coughing and
sneezing.
Low doses often bring a brief feeling of lightheadedness,
mild stimulation followed by a loss of control, lack of
coordination, and disorientation accompanied by
dizziness and possible hallucinations.
In some instances, higher doses can produce relaxation,
sleep or even coma.
38. Potential Effects of Inhaling
Volatile Substances (continued)
If inhalation is continued, dangerous hypoxia may
occur and cause brain damage or death.
Other effects include hypertension and damage to
the cardiac muscle, peripheral nerves, brain, and
kidneys.
Chronic abusers of inhalants frequently lose their
appetite, are continually tired, and experience
nosebleeds.
39. Aerosols
Include spray paints, deodorant and hair sprays, vegetable oil
sprays for cooking, and fabric protector sprays
Often abused not because of the effects produced by their
principal ingredients but rather because of the effects of their
propellant gases
Can be dangerous because these devices are capable of
generating very high concentrations of the inhaled chemicals
40. Toluene
Found in some glues, paints, thinners, nail polishes, and typewriter
correction fluid
A principal ingredient in “Texas shoe shine”
Detectable in the arterial blood within 10 seconds of inhalation
exposure
Highly lipid soluble
Can cause brain damage, impaired cognition and gait disturbances
Liver and kidney damage have been reported
41. Butane and Propane
Found commonly in found in lighter fluid, hair and paint
sprays.
SSDS, and serious burn injuries (because of flammability)
have resulted from abuse
42. Gasoline
A mixture of volatile chemicals, including toluene,
benzene, and triorthocresyl phosphate (TCP)
Because of its widespread availability, young people,
particularly in rural settings, sometimes abuse gasoline
43. Gasoline (continued)
As a mixture of chemicals, its intentional inhalation can be especially
dangerous.
◦Benzene is an organic compound that causes
impaired immunologic function, bone marrow
injury, increased risk of leukemia, and
reproductive system toxicity.
◦TCP is a fuel additive that causes
degeneration of motor neurons.
44. Freons
Freons and other related agents are used in
refrigerators, air conditioners, and airbrushes.
Inhalation can cause not only serious liver damage but
also SSDS.
Inhalation can cause freeze injuries.
45. Anesthetics (e.g. Nitrous
Oxide)
“Laughing gas”: frequently used in outpatient
procedures
Can also be sold in large balloons or small
cylindrical cartridges used as charges for
whipped cream dispensers
46. Nitrous Oxide
Significant abuse problems of nitrous oxide are infrequent,
but there are occasional reports of severe hypoxia or death
due to acute overdoses
Can cause loss of sensation, limb spasms, altered
perception and motor coordination, blackouts resulting
from blood pressure changes and reduced cardiac function.
49. Who Abuses?
Primarily adolescents, but even small children.
More adolescent males than females.
Chronic inhalant users frequently have a profile like that
associated with other substance abusers. That is, often
they live in unhappy surroundings with severe family or
school problems, they have poor self-images, and
sniffing gives them an accessible escape.
http://www.youtube.com/watch?v=3g99h4qaCio
50. Signs of Inhalant Abuse
Often collect an unusual assortment of chemicals (such
as glues, paints, thinners and solvents, nail polish, liquid
eraser, and cleaning fluids) in bedrooms or with
belongings
Have breath that occasionally smells of solvents
Often have the sniffles similar to a cold but without
other symptoms of the ailment
51. Signs of Inhalant Abuse
(continued)
Appear drunk for short periods of time (15 to 60
minutes) but recover quickly
Do not do well in school and are usually unkempt
Sitting with a pen or marker near nose
Constantly smelling clothing sleeves
52. Signs of Inhalant Abuse
(continued)
Hiding rags, clothes, or empty
containers of the potentially
abused products in closets, boxes,
and other places
Possessing chemical-soaked rags,
bags, or socks
Abusable household items
missing
53. Dangers of Inhalants
Sudden sniffing death syndrome
Damage to brain, liver, kidney, heart
Choking on vomit
Accidents associated with “intoxication” and fires
54. The highest rate of
inhalant use by
youths occurs
among Asians.
A. True
B. False
True
False
96%
4%
55. More people die from
inhaling air fresheners
than from inhaling
gasoline.
A. True
B. False
True
False
83%
17%
56. Nitrous oxide has
been used as an
anesthetic by dentists.
A. True
B. False
True
False
0%
100%
Editor's Notes
Depressants = drugs that slow activity in the central nervous system
Include prescription drugs that treat anxiety (sedatives) and insomnia (hypnotics)
As a group, also called sedative-hypnotics
Alcohol is the most widely used depressant
Benzodiazepines are the most widely prescribed depressants
Barbiturates
Barbiturates are used to treat anxiety, insomnia, and seizure disorders. They are not, however, prescribed as often due to the availability of benzodiazepines and non-benzodiazepines. Barbiturates can be addictive and have strong withdrawal symptoms and rebound (exaggerated) effects on rapid eye movement (REM) sleep when they are abruptly stopped and can interfere with sleep. It is advisable, therefore, to stop barbiturates by slowly lowering their dose over a period of more than five or six days. It also is important to use the correct dose of barbiturates since a relatively small overdose may lead to coma or death.
The main differences among barbiturates are their half-lives (duration of their effects). Drugs such as secobarbital sodium and pentobarbital sodium are short-acting, while others such as amobarbital sodium and butabarbital sodium are intermediate-acting, and phenobarbital and mephobarbital are long-acting.
Examples of barbiturates:
Nembutal (phenobarbital)
Mebaral (mephobarbital)
Amytal Sodium (amobarbital sodium)
Butisol (butabarbital sodium)
Seconal Sodium Pulvules (secobarbital sodium)
Can cause confusion, short attention span, impaired cognitive functioning, inadequate emotional control, slurred speech, poor judgment, hangovers, and intoxication
Barbital
Sedative-hypnotic drug used to treat anxiety and nervousness; the original barbiturate
Veronal
Brand name for barbital
Phenobarbital
Second barbiturate developed
Produces relaxation and relieves anxiety
HAZARDS
Reduced attention span
Impaired cognitive functioning
Diminished hand-eye coordination
Inadequate emotional control
Nausea
Vomiting
Birth defects
Confusion
Poor judgment
Slurred speech
Vertigo
Diarrhea
Respiratory failure
Violent behavior
Combination of alcohol and barbiturates can lead to accidental or intentional death
Withdrawal is life-threatening without medical supervision: marked by profuse sweating, insomnia, muscular twitching, paranoia, vomiting, aches and pains, cramps, quick temper, nightmares, hallucinations, and seizures
The effectiveness of barbiturates as sleep agents is questionable, because they interfere with rapid eye movement (REM), and may result in rebound insomnia
Anticonvulsants
These drugs may be used to treat conditions that contribute towards sleep disruption such as restless legs syndrome, nocturnal eating syndrome, periodic limb movement disorder, and insomnia related tobipolar disorder.
Examples of anticonvulsants:
Tegretol (carbamazepine)
Carbatrol (carbamazepine extended-release)
Depakene (valproic acid)
Depakote (divalproex sodium)
Neurontin (gabapentin)
Benzodiazepines and barbiturates
Bond with brain receptors
Enhance the normally inhibitory effects of GABA
Nonbenzodiazepine hypnotics
Selectively target the GABA-A receptor
Seem to work better as sleeping pills than as antianxiety drugs
Include zolpidem (Ambien), zaleplon (Sonata), and eszopiclone (Lunesta)
HAZARDS
Reduced attention span
Impaired cognitive functioning
Diminished hand-eye coordination
Inadequate emotional control
Nausea
Vomiting
Birth defects
Confusion
Poor judgment
Slurred speech
Vertigo
Diarrhea
Respiratory failure
Violent behavior
Combination of alcohol and barbiturates can lead to accidental or intentional death
Withdrawal is life-threatening without medical supervision: marked by profuse sweating, insomnia, muscular twitching, paranoia, vomiting, aches and pains, cramps, quick temper, nightmares, hallucinations, and seizures
Naturally-occurring chemical found in the brain and body
Structurally similar to the inhibitory neurotransmitter GABA
Causes CNS depression, especially when combined with alcohol
Has been used as an anesthetic
Behavioral effects similar to alcohol
Lack of coordination and slurred speech
Considered a date-rape drug
Except for a specific formulation used to treat cataplexy, GHB is listed on Schedule I
Inhalants serve as gateway drugs
Twice as many 8th-grade students use inhalants as 12th-grade students
Strong relationship between inhalant use and other problem behaviors and sensation-seeking
Sudden Sniffing Death Syndrome
http://www.drugfreeworld.org/drugfacts/inhalants/international-statistics.html
22% first time users
Long-term effects: nosebleeds, liver and kidney damage, sores, weight loss, depression, irritability, disorientation, paranoia, hostility, and bone marrow abnormalities
Volatile solvents and other compounds used for intoxicating purposes
Have depressant effects similar to sedative-hypnotics
High-dose exposure causes intoxication, with effects similar to alcohol
Products that can be abused by inhalation include gasoline, glue, paint, lighter fluid, spray cans, nail polish, correction fluid
Volatile solvents (petroleum, acetone, toluene)
Paint, paint thinner and remover, nail polish remover, correction fluid, glues, cements
Overly informative news articles and education programs actually demonstrated how to abuse volatile solvents
Abuse tends to occur as localized fads
Most abusers are very young—solvents are readily available and inexpensive
Aerosols, propellants, gases (butane, propane)
Spray paint, hair spray, lighters, whipped cream
Anesthetics (nitrous oxide, ether)
Current and former medical anesthetics
Nitrous oxide (“laughing gas”) was first used in the early 1800s
Still used for light anesthesia, especially by dentists
Used as a propellant for commercial and home whipping-cream dispensers
Nitrites (isoamyl, isobutyl)
“Locker room,” “Rush,” “poppers”
Relaxes blood vessels which increases blood flow, but also lowers blood pressure.
Used as a treatment for cyanide poisoning.
With high doses there maybe lightheadedness or faintness
Consumer Product Safety Commission has taken steps to remove poppers and other nitrites from the market since 1988
Glue (volatile hydrocarbon solvents)
Psychoactive agent is toluene
Possible immediate cardiorespiratory arrest
Brain damage and memory loss
Anesthetic inhalants
Ether used as industrial solvent and anesthetic
Nitrous oxide (laughing gas)
Can cause irreparable brain damage or death due to decreased oxygen (hypoxia)
Nitrite inhalants
Inhaled for sexual purposes
Amyl nitrite: used to treat angina pectoris and congestive heart failure
Butyl nitrite: found in perfume and antifreeze
Isobutyl: used to treat angina pain; causes vasodilation, flushing, and warmth
Suppresses the immune system
Inhalants serve as gateway drugs
Twice as many 8th-grade students use inhalants as 12th-grade students
Strong relationship between inhalant use and other problem behaviors and sensation-seeking
Sudden Sniffing Death Syndrome
http://www.drugfreeworld.org/drugfacts/inhalants/international-statistics.html
22% first time users
Long-term effects: nosebleeds, liver and kidney damage, sores, weight loss, depression, irritability, disorientation, paranoia, hostility, and bone marrow abnormalities
Kidney damage
Brain damage
Peripheral nerve damage
Irritation of the respiratory tract
Severe headache
Death by suffocation
Inhalants serve as gateway drugs
Twice as many 8th-grade students use inhalants as 12th-grade students
Strong relationship between inhalant use and other problem behaviors and sensation-seeking
Sudden Sniffing Death Syndrome
http://www.drugfreeworld.org/drugfacts/inhalants/international-statistics.html
22% first time users
Long-term effects: nosebleeds, liver and kidney damage, sores, weight loss, depression, irritability, disorientation, paranoia, hostility, and bone marrow abnormalities
Inhalants serve as gateway drugs
Twice as many 8th-grade students use inhalants as 12th-grade students
Strong relationship between inhalant use and other problem behaviors and sensation-seeking
Sudden Sniffing Death Syndrome
http://www.drugfreeworld.org/drugfacts/inhalants/international-statistics.html
22% first time users
Long-term effects: nosebleeds, liver and kidney damage, sores, weight loss, depression, irritability, disorientation, paranoia, hostility, and bone marrow abnormalities
Volatile solvents and other compounds used for intoxicating purposes
Have depressant effects similar to sedative-hypnotics
High-dose exposure causes intoxication, with effects similar to alcohol
Products that can be abused by inhalation include gasoline, glue, paint, lighter fluid, spray cans, nail polish, correction fluid
Volatile solvents (petroleum, acetone, toluene)
Paint, paint thinner and remover, nail polish remover, correction fluid, glues, cements
Overly informative news articles and education programs actually demonstrated how to abuse volatile solvents
Abuse tends to occur as localized fads
Most abusers are very young—solvents are readily available and inexpensive
Aerosols, propellants, gases (butane, propane)
Spray paint, hair spray, lighters, whipped cream
Anesthetics (nitrous oxide, ether)
Current and former medical anesthetics
Nitrous oxide (“laughing gas”) was first used in the early 1800s
Still used for light anesthesia, especially by dentists
Used as a propellant for commercial and home whipping-cream dispensers
Nitrites (isoamyl, isobutyl)
“Locker room,” “Rush,” “poppers”
Relaxes blood vessels which increases blood flow, but also lowers blood pressure.
Used as a treatment for cyanide poisoning.
With high doses there maybe lightheadedness or faintness
Consumer Product Safety Commission has taken steps to remove poppers and other nitrites from the market since 1988
Glue (volatile hydrocarbon solvents)
Psychoactive agent is toluene
Possible immediate cardiorespiratory arrest
Brain damage and memory loss
Anesthetic inhalants
Ether used as industrial solvent and anesthetic
Nitrous oxide (laughing gas)
Can cause irreparable brain damage or death due to decreased oxygen (hypoxia)
Nitrite inhalants
Inhaled for sexual purposes
Amyl nitrite: used to treat angina pectoris and congestive heart failure
Butyl nitrite: found in perfume and antifreeze
Isobutyl: used to treat angina pain; causes vasodilation, flushing, and warmth
Suppresses the immune system
Inhalants serve as gateway drugs
Twice as many 8th-grade students use inhalants as 12th-grade students
Strong relationship between inhalant use and other problem behaviors and sensation-seeking
Sudden Sniffing Death Syndrome
http://www.drugfreeworld.org/drugfacts/inhalants/international-statistics.html
22% first time users
Long-term effects: nosebleeds, liver and kidney damage, sores, weight loss, depression, irritability, disorientation, paranoia, hostility, and bone marrow abnormalities
Kidney damage
Brain damage
Peripheral nerve damage
Irritation of the respiratory tract
Severe headache
Death by suffocation